Ceredex Value Advisors LLC cut its stake in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 23.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 250,350 shares of the health services provider's stock after selling 76,400 shares during the period. Ceredex Value Advisors LLC owned approximately 0.19% of Select Medical worth $8,730,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of the stock. Hexagon Capital Partners LLC raised its stake in Select Medical by 528.7% in the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider's stock valued at $27,000 after purchasing an additional 645 shares in the last quarter. Transcendent Capital Group LLC acquired a new position in shares of Select Medical in the 2nd quarter valued at approximately $35,000. Canada Pension Plan Investment Board bought a new stake in shares of Select Medical during the 2nd quarter worth approximately $39,000. Fidelis Capital Partners LLC acquired a new stake in shares of Select Medical during the 1st quarter worth approximately $47,000. Finally, DekaBank Deutsche Girozentrale bought a new position in Select Medical in the second quarter valued at approximately $60,000. 89.48% of the stock is currently owned by institutional investors.
Select Medical Price Performance
Select Medical stock traded up $3.87 during mid-day trading on Friday, reaching $35.95. The company had a trading volume of 1,546,539 shares, compared to its average volume of 472,234. The business has a fifty day simple moving average of $34.26 and a 200 day simple moving average of $34.07. The company has a market cap of $4.67 billion, a P/E ratio of 16.80, a P/E/G ratio of 1.98 and a beta of 1.42. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 2.11. Select Medical Holdings Co. has a fifty-two week low of $21.28 and a fifty-two week high of $40.50.
Select Medical (NYSE:SEM - Get Free Report) last issued its earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.61 by ($0.01). The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a return on equity of 17.56% and a net margin of 3.97%. Select Medical's revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.61 EPS. On average, equities research analysts predict that Select Medical Holdings Co. will post 2.03 earnings per share for the current year.
Select Medical Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th will be given a dividend of $0.125 per share. The ex-dividend date is Wednesday, November 13th. This represents a $0.50 annualized dividend and a yield of 1.39%. Select Medical's dividend payout ratio is presently 23.36%.
Analyst Ratings Changes
Several research firms have weighed in on SEM. Bank of America initiated coverage on Select Medical in a research note on Tuesday, August 20th. They set a "buy" rating and a $42.00 target price for the company. Benchmark restated a "buy" rating and set a $48.00 price objective on shares of Select Medical in a research report on Friday. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $39.00.
Read Our Latest Stock Analysis on Select Medical
Select Medical Company Profile
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Recommended Stories
Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.